Clinical trial
Impact of Genetic Variation in CES1 on Antiplatelet Therapy
NCT03161678 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Genetic Variation in CES1 on Antiplatelet Therapy
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 22, 2017
- Completion date
- December 12, 2022
- Enrollment
- 111 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myocardial infarction, platelet dysfunction, thrombosis